We have shown that HSP110 expression correlates with MyD88 in patients’ lymph node biopsies and that HSP110, by chaperoning MyD88 and MyD88L265P, enhances ABC-DLBCL cell lines survival [24]. The gene discussed is MYD88; the disease is diffuse large B-cell lymphoma.